Bioactive adrenomedullin as a marker of congestion and disease progression in patients with a systemic right ventricle

Adults with a systemic right ventricle (sRV) are at a high risk for heart failure (HF) hospitalisation and mortality. Bioactive adrenomedullin (bio-ADM) has been proposed as a marker of congestion and prognosis in patients with cardiovascular disease. We aimed to evaluate the association between bio-ADM and mortality and HF events in sRV patients.

Source: International Journal of Cardiology - April 27, 2024 Category: Cardiology Authors: Mohammad Mostafa Ansari Ramandi, Paul M. Hendriks, Adriaan A. Voors, Annemien E. van den Bosch, Joost P. van Melle Source Type: research